Laurus Labs Ltd 2024 IR
The report highlights Laurus Labs' financial, operational, and sustainability performance for the fiscal year 2023-24. Key achievements include the launch of NexCAR19, India's first indigenously developed CAR-T cell therapy, and a multi-year CDMO contract with a leading crop protection company. On the environmental front, the company committed to the Science Based Targets initiative (SBTi) and increased its renewable energy consumption, with solar energy contributing approximately 9% of its total energy use. Additionally, Laurus Labs recycled 284,801 KL of water and maintained zero lost time injuries across its operations.
Company: Laurus Labs Ltd
Sector: Health Care
Country: India
Year: 2024
Type: IR
Pages: 312
Laurus Labs Ltd
Integrated Report
The report highlights Laurus Labs' financial, operational, and sustainability performance for the fiscal year 2023-24. Key achievements include the launch of NexCAR19, India's first indigenously developed CAR-T cell therapy, and a multi-year CDMO contract with a leading crop protection company. On the environmental front, the company committed to the Science Based Targets initiative (SBTi) and increased its renewable energy consumption, with solar energy contributing approximately 9% of its total energy use. Additionally, Laurus Labs recycled 284,801 KL of water and maintained zero lost time injuries across its operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Published
Jun 18, 2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees